Contact this trialFirst, we need to learn more about you.
BET inhibitor
ZEN003694 for Squamous Cell Lung Cancer
Recruiting1 awardPhase 2
Basking Ridge, New Jersey
This trial is evaluating if a drug, ZEN003694, could be an effective treatment for advanced squamous cell lung cancer with a mutation in the NSD3 gene. It works by blocking proteins that may counter the effect of NSD3 on tumor growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service